Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | 31 | 0 | 2 | 0 | 73,50 € | 83,92 € | 14,18 % |
| Gilead Sciences Inc | 11 | 1 | 1 | 0 | 70,06 € | 85,27 € | 21,72 % |
| Ultragenyx Pharmaceutical Inc. | 23 | 1 | 1 | 0 | 41,80 € | 86,28 € | 106,41 % |
| Sanofi S.A. | 3 | 0 | 0 | 0 | 97,81 € | 99,50 € | 1,73 % |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | 88,15 € | 100,00 € | 13,44 % |
| BioMarin Pharmaceutical Inc. | 19 | 0 | 2 | 0 | 79,40 € | 102,61 € | 29,23 % |
| Ipsen S.A. | 1 | 0 | 0 | 0 | 100,90 € | 109,00 € | 8,03 % |
| Novartis AG ADR | 3 | 0 | 1 | 0 | 102,00 € | 112,40 € | 10,19 % |
| Abbott Laboratories | 19 | 0 | 1 | 0 | 98,86 € | 116,25 € | 17,59 % |
| Merck & Co. Inc. | 30 | 1 | 0 | 0 | 117,20 € | 124,97 € | 6,63 % |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | 137,35 € | 130,00 € | -5,35 % |
| Neurocrine Bioscience | 35 | 0 | 4 | 0 | 134,55 € | 143,34 € | 6,54 % |
| Novo Nordisk A/S ADR | 20 | 1 | 2 | 0 | 119,00 € | 145,75 € | 22,48 % |
| Merck KGaA | 3 | 2 | 0 | 1 | 155,10 € | 146,00 € | -5,87 % |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | 125,00 € | 150,00 € | 20,00 % |
| AstraZeneca plc | 2 | 0 | 0 | 0 | 142,55 € | 165,00 € | 15,75 % |
| AbbVie Inc. | 28 | 0 | 4 | 0 | 168,98 € | 176,30 € | 4,33 % |
| Repligen Corp. | 13 | 0 | 1 | 0 | 121,20 € | 182,96 € | 50,96 % |
| Jazz Pharmaceuticals plc | 27 | 0 | 1 | 0 | 101,50 € | 184,92 € | 82,19 % |
| Krystal Biotech | 17 | 0 | 0 | 0 | 190,80 € | 186,59 € | -2,21 % |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | 185,00 € | 195,00 € | 5,41 % |
| Johnson & Johnson | 39 | 1 | 4 | 0 | 146,88 € | 195,31 € | 32,97 % |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | 169,68 € | 200,06 € | 17,90 % |
| BeiGene Ltd ADR | 9 | 1 | 0 | 0 | 148,00 € | 241,54 € | 63,21 % |
| Charles River Labs Intl | 12 | 0 | 1 | 0 | 205,40 € | 248,57 € | 21,02 % |